Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (341-350 of 504) with videos related to

Pageof 51
Sort By:
Leukemia & Lymphoma|October 9, 2012
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemiaLorenzo De Paoli, Michaela Cerri, Sara Monti, et al.
British Journal of Haematology|July 22, 2021
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphomaRiccardo Moia, Chiara Favini, Valentina Ferri, et al.
Blood Advances|March 4, 2020
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma modelsChiara Tarantelli, Martin Lange, Eugenio Gaudio, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
British Journal of Haematology|November 25, 2015
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartmentsIlaria Del Giudice, Marilisa Marinelli, Jiguang Wang, et al.
Blood|May 24, 2014
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 studySara Bringhen, Maria Teresa Petrucci, Alessandra Larocca, et al.
Hematological Oncology|February 26, 2020
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patientsMarta Lionetti, Marzia Barbieri, Vanessa Favasuli, et al.
Blood Advances|September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumabAlessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
British Journal of Haematology|July 13, 2017
NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation typesTiziana D'Agaro, Tamara Bittolo, Vanessa Bravin, et al.
Nature|March 11, 2011
Inactivating mutations of acetyltransferase genes in B-cell lymphomaLaura Pasqualucci, David Dominguez-Sola, Annalisa Chiarenza, et al.
Pageof 51

Showing results (341-350 of 504) with videos related to

Sort By:
Pageof 51
Leukemia & Lymphoma|October 9, 2012
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemiaLorenzo De Paoli, Michaela Cerri, Sara Monti, et al.
British Journal of Haematology|July 22, 2021
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphomaRiccardo Moia, Chiara Favini, Valentina Ferri, et al.
Blood Advances|March 4, 2020
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma modelsChiara Tarantelli, Martin Lange, Eugenio Gaudio, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
British Journal of Haematology|November 25, 2015
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartmentsIlaria Del Giudice, Marilisa Marinelli, Jiguang Wang, et al.
Blood|May 24, 2014
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 studySara Bringhen, Maria Teresa Petrucci, Alessandra Larocca, et al.
Hematological Oncology|February 26, 2020
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patientsMarta Lionetti, Marzia Barbieri, Vanessa Favasuli, et al.
Blood Advances|September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumabAlessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
British Journal of Haematology|July 13, 2017
NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation typesTiziana D'Agaro, Tamara Bittolo, Vanessa Bravin, et al.
Nature|March 11, 2011
Inactivating mutations of acetyltransferase genes in B-cell lymphomaLaura Pasqualucci, David Dominguez-Sola, Annalisa Chiarenza, et al.
Pageof 51